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Abstract
Objective To explore men’s lived experience of advanced
prostate cancer (PCa) and preferences for support.
Design Cross-sectional qualitative study applying openended surveys and interviews conducted between June
and November 2016. Interviews audio-recorded and
transcribed verbatim and analysed from an interpretive
phenomenological perspective.
Setting Australia, nation-wide.
Participants 39 men diagnosed with advanced
PCa (metastatic or castration-resistant biochemical
progression) were surveyed with 28 men subsequently
completing a semistructured in depth telephone interview.
Results Thematic analysis of interviews identified two
organising themes: lived experience and supportive care.
Lived experience included six superordinate themes:
regret about late diagnosis and treatment decisions,
being discounted in the health system, fear/uncertainty
about the future, acceptance of their situation, masculinity
and treatment effects. Supportive care included five
superordinate themes: communication, care coordination,
accessible care, shared experience/peer support and
involvement of their partner/family.
Conclusions Life course and the health and social context
of PCa influence men’s experiences of advanced disease.
Multimodal interventions integrating peer support and
specialist nurses are needed that more closely articulate
with men’s expressed needs.

Introduction
Prostate cancer (PCa) is the second most
common cancer in men with the highest
incidence in Australia/New Zealand and
North America.1 Most men present with
localised disease or disease with regional
lymph nodes spread with the relative 5-year
survival rate for these men exceeding
95%.2 3 However, one in five will progress
to metastatic disease.4 Approximately 5% of
men are diagnosed with metastatic disease
and the relative 5-year survival rate for these
men is only 30%.3 5 The mainstay treatment
for advanced PCa is androgen deprivation
therapy (ADT) that typically is followed
by progression to metastatic castration-resistant PCa.6 Once this occurs, median

Strengths and limitations of this study
►► Extends previous research in men with ad-

vanced prostate cancer to describing how masculinities, life course and the broader social and public
health context influence support needs.
►► Robust and transparent study method and the application of a phenomenological approach.
►► Valid and reliable and transferable within the
Australian setting.
►► Cross-sectional design is a study limitation.

survival is less than 2 years,7 although
recent therapeutic advancements such as
abiraterone acetate and enzalutamide have
shown potential for further slowing disease
progression8 with median survival up to 3
years.6 The STAMPEDE9 and LATITUDE10
trials demonstrated a survival advantage
for the combined use of abiraterone with
commencement of ADT; however, this
was offset by earlier and more prolonged
androgen suppression and a higher risk of
grade 3–5 adverse events.
Hence, while new treatments for advanced
PCa prolong life, this means men are living
longer with the effects of treatment and
disease progression including deteriorating bone health, pain, hot flushes, loss
of libido, erectile dysfunction, increased
fat mass, sarcopenia, fatigue and cognitive decline.6 11 12 Men with advanced PCa
have poorer quality of life, higher levels
of psychological distress, increased suicide
risk and more unmet supportive care
needs compared with men with localised
disease.13–16 Approximately one in four
experience regret about treatment decisions and this is associated with poorer
quality of life and increased distress.17 In
sum, the burden associated with advanced
PCa is substantial and further evolving as
new treatments emerge.
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Method
Study design
This study applied a cross-sectional qualitative design.
In a first step, participants reflected on their experience
with advanced PCa via a mail administered open-ended
survey. These responses provided a context to inform
development of a protocol to guide subsequent semistructured in-depth telephone interviews. Consistent
with the study aim to describe men’s lived experiences
in the context of advanced PCa, we adopted an interpretative phenomenological perspective.24 25
Participants and recruitment
Participants were recruited from an existing patient
cohort.15 In brief, this was a cohort drawn from treatment centres across Australia with participants from
five Australian states. In June 2016, we contacted men
who had not withdrawn from the cohort and were
not to our knowledge deceased and had consented to
future contact (n=141). In all, 39 men returned the
survey (28% response) and of these 28 were available
for telephone interview between September 2016 and
November 2016 (72% response). Similar to the cohort
from which participants were drawn, the mean age of
participants was 72.7 years (SD=8.5; range 58.2–94.6)
with the majority born in Australia (75%), married
(86%) and retired (79%); men resided across four
2

Table 1 Sociodemographic characteristics and treatment
information for participants completing an open-ended
survey and telephone interview
Received
hormone
treatment
(Y/N/NR)

Participant ID

Age (years)

Time since
diagnosis
(years)

P3
P5

70
67

8.0
NR

Y
NR

P6

90

4.2

Y

P7

69

4.3

Y

P8

69

7.0

Y

P9

69

3.9

Y

P10

86

3.2

Y

P12

72

14.4

Y

P14

67

4.0

Y

P15

71

11.5

Y

P17

95

10.3

Y

P18

75

16.0

Y

P19

78

5.4

Y

P20

69

5.8

Y

P21

70

15.1

Y

P23

79

12.0

Y

P24

72

22.8

Y

P25

61

2.7

Y

P26

76

7.8

Y

P27

64

8.1

N

P30

58

6.0

Y

P31

59

4.8

N

P32

70

4.2

Y

P33

74

6.8

Y

P34

70

6.0

N

P35

78

4.4

Y

P38
P39

76
83

NR
2.1

NR
Y

N, no; NR, not reported; Y, yes.

Australian states. With regard to educational level,
7 men had a college degree, 15 had a trade or technical certificate/diploma, 2 had completed senior
high school and 4 had completed junior high school.
Mean time since diagnosis was 7.7 years (SD=5.0; range
2.1–22.8). Most men were treated with ADT (88%), 73%
radiation therapy and 62% prostatectomy. Men who
did not participate were either too unwell (n=4), had
a hearing impairment (n=1) or did not consent (n=6).
Table 1 reports sociodemographic characteristics and
treatment information for each interview participant.
Data collection
Men responded to four questions in the survey about their
PCa-related concerns: assistance or support accessed for
Chambers SK, et al. BMJ Open 2018;8:e019917. doi:10.1136/bmjopen-2017-019917
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To date there is scant psychosocial or supportive
care intervention research directly targeting men with
advanced PCa and the one randomised trial of scale
completed by our team failed to prove effectiveness.15 18
Researchers in Canada and Scotland have previously
highlighted the persisting support services gap for
men with advanced PCa and suggested more qualitative research elucidating men’s experiences is needed
if we are to develop effective supportive care interventions.19 20 Carter et al in 2011 explored the supportive
care needs of men with advanced PCa and concluded
that functional issues, information needs and emotional
distress were the three domains of need that needed
to be addressed.19 More recently, Paterson et al (2017)
interviewed eight men with advanced PCa describing a
broader range of challenges extending to interpersonal
and intimacy needs.20 Both studies emphasised the
gap in informational support for these men; however,
neither deeply explored issues related to masculinities nor the broader social and public health context
in which this illness experience is nested.21–23 We
sought to extend this previous work more specifically
connecting our enquiry between men’s challenges in
facing advanced PCa and their preferences for support
within their social context. Accordingly, we applied an
interpretative phenomenological approach to describe
the lived experience of men with advanced PCa (proven
metastatic or castration-resistant biochemical regression) and their supportive care preferences.

Open Access

Focus area

Question

Health system Thinking about your medical treatment, what changes do you feel would make medical services better meet the
needs of men with advanced prostate cancer?
Supportive
Thinking about the treatment side effects that a man with advanced prostate cancer might experience, what
care needs
sort of support would help most?
Thinking about the future and the worries that face a man with prostate cancer that has advanced or recurred,
what sort of support would help most?
Barriers

In developing services to help men cope or manage better with advanced prostate cancer, can you describe
support approaches or ways of helping that would not be acceptable to men? For example, supportive
approaches that would turn men off or away?

Preferred
approaches
Other

In developing services to help men cope or manage better with advanced prostate cancer, can you describe
support approaches or ways of helping that would be more attractive to men?
Thinking about what we have spoken about today, is there anything else we haven’t covered that you think is
important to supporting men with advanced prostate cancer?

these concerns and from whom, other support needed
and preferences for support for men. Thematic analysis26 of responses (MKH, KL, SKC) indicated four areas
that were challenging for men and in which they lacked
support: information, medical care, side-effects and
the future. Three experienced female interviewers in a
research fellow or research assistant position with postgraduate training in the behavioural sciences (ML, KL,
EE) conducted telephone interviews to further explore
the key areas identified. Interviews were on average
62.1 min in length (SD=19.2; range=29.2–111.9 min).
Member checking occurred at the beginning of each
interview during which the interviewer asked participants
to comment on the accuracy of researcher interpretation
of survey results and gave participants the opportunity
to add anything they thought had been missed. Interview questions (table 2) explored in greater depth the
concerns previously identified in men’s survey responses:
health system concerns, supportive care needs, barriers
to support and preferred approaches. Participants were
invited to discuss other aspects of their experience that
they considered were important. Interviews were audio-recorded and transcribed verbatim.
Data analysis
Interview transcripts were analysed using thematic analysis.26 27 Themes were derived inductively from the data
by reading and re-reading the interview narratives and
from this developing an understanding of men’s lived
experience through their words. Coders had social and
behavioural science (SKC, MKH, JD, KL) and nursing
(SKC) backgrounds with a wide range of experience from
2 to 20 years working in psycho-oncology and PCa research
and included male and female researchers. Transcripts
were coded iteratively with constant comparison between
the codes generated and the data to ensure that consistent
and diverging responses were incorporated. Two research
team members independently coded one-third of the
transcripts and generated a preliminary coding scheme
(MKH, KL). This coding scheme was further refined with
Chambers SK, et al. BMJ Open 2018;8:e019917. doi:10.1136/bmjopen-2017-019917

a third (SKC) and fourth (JD) research team member.
Once all interview transcripts were included, the coding
scheme was further reviewed and agreed on by all coders.
Exemplar responses were identified across transcripts to
illustrate and confirm labelling of themes. Reporting of
data is consistent with consolidated criteria for reporting
qualitative studies (COREQ) guidelines.28
Results
Thematic analysis identified two organising themes: lived
experience and supportive care. The first organising
theme reflected men’s lived experience with advanced
PCa and within this six superordinate themes. The second
organising theme captured elements of supportive care
that men found challenging and their preferences for
how care should be delivered with five superordinate
themes. Figure 1 depicts the coding structure. Tables 3
and 4 present illustrative quotes for each superordinate
theme.
Lived experience
Men’s lived experience with advanced PCa included six
superordinate themes: regret about late diagnosis and
treatment decisions, being discounted in the health
system, fear/uncertainty about the future, acceptance
of their situation, masculinity and treatment effects
(table 3).
Regret about late diagnosis and treatment decisions
Most men described feeling regret about late diagnosis or
treatment and this was commonly attributed to delays by
clinicians. Many men perceived these delays were caused
by general practitioners and/or specialists who would
not perform digital rectal examinations or prostate-specific antigen (PSA) testing, did not detect PCa until it
was well advanced despite regular testing and did not
refer patients for further treatment or testing in a timely
manner despite men’s requests for them to do so. From
this, some men were left with a distrust of the medical
3
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Table 2 Interview questions
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Coding structure derived from thematic analysis.

profession. Many men also discussed regretting their
treatment choices and not having had a second opinion
so that they felt more adequately informed and clearly
understood the outcomes of treatment, including side
effects and how these could be managed.
Being discounted in the health system
In their interactions with clinicians, most men described
their concerns, needs and autonomy as discounted or
ignored. Many men felt devalued and believed they were
somehow less important in the broader health system.
In their experience, PCa was the ‘poor cousin’ of breast
cancer in terms of funding, research focus and controversy over the value of PSA testing and less effort by
the government and non-profits to promote awareness
of PCa. Some men also considered that they and their
cancer were less important due to their older age and
community attitudes where PCa is considered a cancer
that may not lead to death.
Fear/uncertainty about the future
An uncertain future was discussed in terms of most men
needing to make ‘the unknowable’ a known entity by
4

understanding how much time they may have left to live,
what lies ahead for disease progression and quality of life,
potential treatment options and next steps for support
when all treatment options had been exhausted. This
information was critical to their ability to feel more in
control and to prepare for the future both psychologically
and practically while they were well enough to do so. By
contrast, some men discussed not wanting to know what
the future held in order to focus on their day-to-day life.
Acceptance
Many men used their age as a frame to accept physical changes and the threat to their mortality. Other
approaches adopted by many men to reach acceptance were focusing on ‘getting on with it’, and viewing
ongoing physical effects of the disease or its treatment
as part of life, an inevitable outcome of treatment or
disease progression and as a favourable alternative to
death. Regarding sexuality, some men found changes in
their physical capacity to have sex an ongoing cause of
distress. Other men shifted their focus to other aspects
of their relationships (eg, expressing intimacy in ways
Chambers SK, et al. BMJ Open 2018;8:e019917. doi:10.1136/bmjopen-2017-019917
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“I’d just like to know where I’m headed. I guess he can’t tell me what’s going to happen with the disease, but I’d imagine
there must be a pattern, a reasonable pattern of what happens. I mean, with some illnesses you know this is going to
progress from this to that, to that, but an article I saw recently in a support group pamphlet was, if you took Drug X tablets,
when they stopped working, you took Drug Y tablets. When they stopped working, the next thing on the—on the ladder
was death, d-e-a-t-h. Well, I’ve been taking Drug X for quite a while. I’ve been taking Drug Y for quite a while. Each had a
definite effect on my PSA, each lost that effect. So really, the next thing that faces me is death. Now, so, it was 4 months
ago that my oncologist gave me, he said, ‘You’ll see your birthday.’ Well, that’s only 3 months away, it’s only 2 months away
actually. What’s going to happen between now and then?” (P6)
“I think acceptance. That would be the word that comes to mind. Not resignation, big difference in my mind between
resignation and acceptance, but okay, I accept it, to live a bit longer, or feel a bit better (erectile dysfunction). This is what
happens, I've just got to come to terms with it the best way I can. I didn't handle it too well. I think even at that age, you
think you're indestructible. Gees, it did happen. But, it's not the end of the world and that's the attitudinal part, I think, more
so than—attitude in retrospect, acceptance and spirituality part of it…I can possibly liken it, sort of, something akin to grief
counselling is what I needed. You know, there's anger, there's frustration, everything. The whole gambit. It's all there. It's
like, okay, it's passed away now, you know, let it rest…I just assumed, pop a couple of Viagra, you'll be right. But, no. So,
yeah, it's—yeah and that's a problem after being very active for such a long time with a beautiful wife, it's really hard, really
hard to take.” (P30)
“Partly, I think, the reluctance of men to talk about their health, or to talk about personal issues that the idea of maleness,
being able to be stoic and cope, type of thing. And just in the idea of maleness, that, sort of, men don’t cry, men are stoic,
or you get on and cope with things, a lot of men have not been exposed to talking about personal matters and so find it
difficult to do that.” (P9)

Fear/uncertainty about the future

Acceptance

Masculinity

BMJ Open: first published as 10.1136/bmjopen-2017-019917 on 17 February 2018. Downloaded from http://bmjopen.bmj.com/ on 22 October 2018 by guest. Protected by copyright.

Continued

“I saw a GP and first of all, I think it was 1.9 was my PSA reading, and when it got to 14 I said to him—everything I read
tells me that I should be seeing a specialist. And he said, ‘Oh you worrywart, don’t worry about it,’ and then next time I said
it, he said, ‘All right I’ll send you to see […] he’s a urologist.’ I went to see his specialist mate, and he said, ‘Bloody hell,
where’ve you been, you should’ve been here 3 years ago.’ Because it’d been like that for 3 or 4 years. The prostate was full
of cancer, and it escaped outside the prostate and went into my lymph nodes, because of all that time wasted.” (P31)
“My only regret was that I didn’t get enough information at the beginning, or, hey, maybe I did, but I was never comfortable
with the fact that I had really learnt everything that there was to learn about it before I actually made decisions, and I may or
may not have made the wrong one.” (P32)
“The men seemed to think that prostate cancer was a B grade compared to other cancers. Because it was older men, and
they’d had their run probably. No-one’s going to worry too much about it…Usually men who have got prostate cancer are
old, older men and certainly you wouldn’t all the funding going to the old men and not the young women, or middle-aged
women. It wouldn’t be fair would it. So we thought that the prostate cancer people were sort of the poor relations in both
attitude, funding, in a lot of ways. But you can’t change it.” (P26)
“They treat you more as a joke, yeah, and the last time I spoke to him about it– I tried to find out am I going to have a lot of
pain, is my bones going to break or whatever? He said: You’ll probably die of pneumonia.”(P6)
“I just got the impression that the patient was just a number, the name didn’t matter, in fact, we won’t even involve the
patient in the discussion, they’re there but we’ve just got a number for him on the records and when they come around to
your bed the team, which could be a half a dozen or 10 or even more depending on how many people they’ve got on the
day, they just start talking about the condition you’ve got, absolutely nothing, no mention of you yourself being the patient,
they don't even recognise you.” (P20)

Regret about late diagnosis and treatment
decisions

Being discounted in the health system

Exemplar quotes

Lived experience organising theme and superordinate themes

Superordinate theme

Table 3

Open Access
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Exemplar quotes
“I’m impotent, and that—put it this way, that's—honestly, that’s something that I have an extremely hard time coming to
terms with. My wife and I had a fantastic sex life but that’s gone and there's now—yeah, it’s probably as much my fault as
hers but there's just nothing left of our marriage; we live together but that’s about it.” (P38)
“I can’t even walk down the beach, put out—not having to urinate a couple of times, I take my dog for a pretty long walk
each day and I’m looking over my shoulder and I’m always thinking one day I’m going to get busted and someone’s going
to call me a dirty old man and are they going to even be prepared to listen to the fact that I’ve had prostate cancer and it's
not my fault?” (P14)
“Eating is a problem, I have a problem eating. I don’t really want to eat but I more or less force myself to eat, because I
have no energy, but I’ve lost, I think, it’s 40 kilos all together, but that’s over a period. When I look in the mirror I see this
gaunt face looking at—I thought I was fairly good looking for an old bloke but now I really look bloody painful, I take notice,
like, god I’m gaunt. And I really am thin.” (P19)
“The general fatigue, loss of energy, loss of muscle tone, the hormonal issues were probably the biggest ones. I’ve got
osteoporosis because—it’s only at the early stage, but my bone density is checked regularly, but it’s dropping slowly even
though I do exercise, walk a lot and keep my weight down and exercises up. I do that sort of thing all the time. But I’m
probably holding it in check. But that one’s always a bit of a concern. I’ve got to be careful I don’t fall off the roof, I don’t
do something, don’t break anything nowadays. In fact I—when I finished radiation therapy I felt all pretty smart and I went
running on the rocks at the beach one day, and jumped from one rock to another, and snapped my ankle so badly it had to
be screwed up with screws and braces.” (P5)
“I now have gynecomastia which I’ve discussed with my GP and my specialist. I was looking at having my breasts
removed, unfortunately which I would’ve had to pay for, but I was told that if I did, they would come back so it would be a
waste of time and effort and money doing it.” (P38)
“I know the cancer’s spreading. I woke up this morning about 4 o’clock with pains in my pelvic, where it is, the pelvic bone
where I suspect the cancer’s moving to. They said it would at the Cancer Clinic, so that gave me a bit of pain. But I find
if I take Panadol, one of these Panadols—I take two at night and two in the morning and two midday, I keep the pain at a
level that’s quite acceptable. But I didn’t take it last night and then I woke up at 4 o’clock and thought, oh, what’s going on
here.” (P23)
“I mean one of the biggest impacts is financial loss and that is not discussed full stop. That’s when you’re diagnosed with
a terminal illness and there is no cure. They can slow the disease down, which they’ve successfully done in my case.
But because of the side effect of loss of testosterone, so you’ve got less energy, muscle wastage and all of that. And the
end resulted in me—I had to give up work. Now, that financial loss has been—made a big impact on my retirement and
everything else.” (P3)

Treatment effects

Continued
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Superordinate theme

Table 3
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Continued

“For me at my stage, or more advanced, or—I don’t know at what stage I’m at. Whether I’m advanced or reasonable,
or what. I don’t have any—I don’t have any real—I don’t know what the symptoms are—if you do get advanced or more
advanced, I don’t know what the symptoms are really. I have no information in that regard. I don’t know.” (P17)
“He’s not exactly verbose, he doesn’t say a great deal. And I got put on Drug Z and was more or less left to my own
devices with my GP who I don’t think he’d ever heard of it and it wasn’t really until about 3 or 4 months ago that we
managed to sort out how the injections should be given.” (P10)
“Openness, I think, for me for the treatment options. Probably the side effects were less discussed or less publicised. There
was some, particularly in the radiation process, you could get burning, you could get itching, this, or that, but then later on
you find out there was some others that they didn’t mention…On that score, I think there’s some minor explanation, you will
get tireder, you will get hot flushes, but no advice—what can you do about a hot flush; go and have a cold shower. There’s
been nothing on that, and in terms of maybe a medication, is there something will help as it does for ladies, I’ve got no
idea.” (P35)
“You just get the impression going through the process that the different stages of the process all have their own people,
their own separate team altogether. I guess, I could sum it up in a word and that’s coordination with all the different
treatments and tests and results and everything to do with the treatment, all those things are there obviously, patients are
being treated for a long, long time, but having been through the process I just find that even though you end up getting
through it it's a bit of a minefield for the patient because they haven’t got a clue really what’s involved, what’s coming next,
what you’ve got to do.” (P20)
“It’s got to be the doctors. The doctors, I think, it has to start at the GP level and go right through. This is, as I say, this is
your life and they’re doing the journey with you. That’s a good way of putting it, they’re doing the journey with you.” (P15)
“I’d say ideally at time of diagnosis, after you talk to the doctor the next step would be the prostate cancer nurse. Yeah.
Into the treatment part of it, yes, as part of the treatment process. But, in some ways, I think, that if you’ve got, say, sort
of a trusted person, so if it’s a prostate cancer nurse providing good information and directing traffic, type of thing, and
putting people in touch with resources, I think, that’s probably going to help to overcome the difficulties.” (P9)
“I think this support idea needs to be built in at diagnosis level into the, well, the doctors would present this as, “This is a
natural part of the treatment, we’re not saying go there if we think you need it, you have been diagnosed with cancer, you
need it, we would strongly recommend you take your—take the benefit of going to a group for,’ I don't know how many
meetings, but a few. And I also think that—how you do it I don't know, but that it gets presented—it is presented to men as,
‘This is what you do, there is no loss of dignity in going and talking over your problems with people who are in the state—in
the same position as you are.’” (P39)
“Well I’m up in the country and when I got diagnosed there was really no services in my town and it was a, you know
an hour and a half trip to the closest place where could get anything done…Well they certainly—they didn’t even have
chemotherapy services here. And they didn’t have helpers such as prostate nurses etcetera, people that were specifically
trained in this sort of cancer. My oncologist, my urologists are all down in Melbourne. I mean they’re 2 hours away in a
motor car.” (P34)
“It’s about $40 000 a year. I think it’s about 4 to 12, about $4000 a month I think. Which the majority of people can’t afford
anyway. So he’s got a number of other drugs, too. But that’s the one he’d like to use next for me. So we’ve got to deal with
that when we get there.” (P5)
“I definitely would (go to another support group). The problem is I can’t drive anywhere at the moment because of some of
the drugs I’m on; so it makes it very difficult for me to get anywhere. And now the closest group other than this one, even
that one I had to go by car, but the next area’s group is probably about twice the distance away and nowhere near public
transport.” (P27)

Communication

Care Coordination

Exemplar quotes

Supportive care organising theme and superordinate themes

Superordinate theme

Table 4
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“And I think that’s—the big help that people need, and they are finding it here because they come to support group, it’s
looking for some comfort, I think, or some advice, or to talk to someone who’s been there and done that. I think that a
lot of trouble with the GPs and the surgeons, they—a lot of them don’t have that first-hand experience, even though they
work with it every day of their lives they don’t—they haven’t had the actual experience of living with the disease first-hand
anyway.” (P5)
“I think if you had someone or a little group of people who could meet and talk and have—maybe even in a coffee shop,
have a cup of coffee, even the pub, have a beer or coffee or something and discuss your problems because that’s where
you’ll find out that most of the people have problems the same as you. You get some men together, you can have someone
facilitate it at first, then you just leave them and come back later on.” (P19)
“Yeah, well face-to-face is the best way, but yeah, online, why not? Particularly with people in the country, assuming they
know how to go online and handle IT and all that sort of thing. Yeah, somebody or some group of people that they can
contact who do have the experience and have the understanding.” (P21)
“From a personal standpoint of view, the normal sort of prostate cancer support group hasn’t been of any real benefit to
myself or my wife. And the reason advanced prostate cancer for now, based in south east Queensland, which covers all of
Australia and we have a monthly telephone conference and that is, yeah that’s quite beneficial. Because everybody in it has
got advanced prostate cancer. It’s just that yeah, I’ve got advanced metastatic prostate cancer and that’s what this group
is particular for, for men with advanced. Because we joke and say we among ourselves, ‘Dead Men Walking Club.’ Warped
sense of humour.” (P3)
“And, I know, I found going to the support group, I walked into the room, I sat by myself and I didn’t sort of mix with the
other men, but that unfortunately is me. I’m not a mixer, I’m not a conversationalist, although I seem to be talking pretty
well to you. So I found them, it felt a bit uncomfortable. For those who have been there a long time, they were starting to
hear the same thing over and over again. So I guess that might have been why I terminated going, one of the reasons.
Very well run group, I just lost, I felt I was getting no benefit out of it and I wasn’t really comfortable there. That’s me, my
particular makeup you can understand.” (P6)
“She (wife) senses my feelings, my moods, and she can tell if I’m feeling a bit negative by my comments or my talk, or
mostly my body language. And she doesn’t beat around the bush, she just tells me to snap out of it, or, ‘Pull yourself
together,’ or ‘get yourself sorted’. 'Why don’t you do this, or why don’t you do that?’ She doesn’t muck around, she really
socks it to me, which is really good, it’s what I need. And I know that a lot of men say the same thing, they are always
grateful for their partners in many, many cases, and we really live a lot longer with good wives, I can assure you. My wife is
definitely the pinnacle. She’s the main support there.” (P5)
“So, I get help with transport and I have someone come and help me clean once a fortnight and that, but I probably need
help with shopping, but I have friends who will go and do the shopping or take me shopping. So, I’m fairly well off in that
regard. So, yeah, it’s good to have someone who will help you, you don’t want them mothering you, but take you and if I
needed shopping we would go shopping after we’d been to the gym, heavy shopping, I need it, and bring it home.” (P19)

Shared experience/peer support

Involvement of partner/family

Exemplar quotes

Continued
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Table 4
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Masculinities
Male values and masculinities were discussed as central to
most men’s experience of PCa, support and coping. Many
men believed that as a group they do not look after themselves, go to the doctor, ask for help or talk about their
problems by comparison to women and have a different
view on their health, are less prepared to discuss their
health and gave health less attention. This reluctance to
seek help or support or talk about their problems was
ascribed to male values around being strong, capable, independent/autonomous or stoic. Many men used avoidance
as a coping approach by avoiding thinking or talking about
their situation and covering up or ignoring side-effects or
a need for support. Some men expressed concerns that
there would be negative consequences socially or in their
employment if others knew about their cancer. Privacy and
being embarrassed talking about personal issues were also
raised by many men. Viewing sexuality and sexual function as important to their identity as a man meant that
some men were deeply troubled by changes in sexuality
and believed that their relationship with their partner now
would be negatively impacted or that it would no longer be
possible for them to start new relationships with women.
In their perceived role as ‘the provider’ and ‘the
protector’, some men expected to give help rather than
receive it. Some men tried to protect their wives or their
family by not talking about their problems and thus
avoid worrying them. Many also adopted approaches
to promote adjustment including being optimistic and
‘getting on with it’, taking responsibility for their health
and well-being (eg, remaining physically active) as well as
an action-oriented approaches in which they identified
and solved problems directly or sought help or support.
In using these approaches, men saw themselves as uninhibited by masculine norms, which typically constrain
help seeking. Many men devalued ‘talk’ as a way to obtain
support and viewed psychologists as not able to provide
the solutions they needed, also describing unfavourable
attitudes towards support groups as an opportunity for
self-pity or drama.
Treatment effects
All men discussed the effects of advanced PCa and its
treatment that affected their quality of life, relationships, capacity to do daily tasks and for many men were
highly distressing. Prominent among these were physical
effects and financial concerns. Physical effects included
the inability to obtain an erection, lack of libido, urinary
incontinence, changes in appearance and bodily structure including gynecomastia, weight gain, sarcopenia,
decreased bone density, fatigue, dizziness, loss of balance,
breathlessness, hot flushes, cognitive changes and pain.
Some men discussed no longer being well enough to
work and that this negatively affected their income and
retirement plans.
Chambers SK, et al. BMJ Open 2018;8:e019917. doi:10.1136/bmjopen-2017-019917

Supportive care
The organising theme supportive care included five
superordinate themes: communication, care coordination, accessible care, shared experience/peer support
and involvement of their partner/family (table 4).
Communication
Men had mixed experiences in their interactions and
communication with health professionals. Four pivotal
points in the care trajectory in which effective communication appeared most critical were: diagnosis, deciding
on treatment options, treatment effects and symptom
management and follow-up care. Many men described
being unclear about the specifics of their diagnosis (eg,
staging, PSA) whereas, by contrast, some men appreciated the direct and honest approach adopted by their
clinicians when communicating about the severity of their
disease. When discussing treatment options, men desired
more guidance and support in making a treatment decision and for options to be more clearly communicated
so that they could better understand long-term treatment
effects. Some men were dismayed that their general practitioners (GP) or other health professionals did not seem
to have specialised knowledge about PCa. Preferred decision support included clear, unbiased communication
about the pros and cons of each treatment option and
referral to other sources of information that men could
consider in their own time.
Some men described confusion and frustration
when they were given a treatment that they needed to
self-administer (eg, injections) but were not effectively
instructed in how to do this. Men commonly discussed
health professionals’ communication about treatment
side-effects as insufficient (eg, told about effects but not
how to deal with them) and selective (eg, told about immediate but not long-term effects) and as a consequence felt
unprepared and isolated in their experience. Some men
described not being listened to when they raised their
concerns or being unable to get clear answers to questions. Some men expressed that it was up to them to find
solutions to manage their side-effects because clinicians
did not adequately address these.
Care coordination
For some men, regular ongoing communication with
their clinicians was a source of support; however, other
men felt out of touch and isolated due to the length of
time between each consultation. GPs were important to
some men in helping them feel connected with their care
team. Most men discussed the need for better coordinated care and information and this was focused on three
aspects: communication between health professionals,
having a ‘middle man’ and integrating psychosocial
support as part of routine care.
A lack of communication between specialist clinicians
regarding treatment and referral was discussed by many
men as problematic. Men had mixed views as to who
should be the central point of call for information and
9
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that do not require an erection) as a way to accept their
situation.
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Accessible care
Many men discussed three main barriers to accessible
care: geographic location, ill health and financial cost of
treatment. Some men experienced difficulty accessing
services because they resided in a regional or rural location where services were either not available or required
them to travel long distances with resultant cost and inconvenience. Some men had difficulty or were prevented
from accessing central or nearby services due to ill health
or fatigue; and some men discussed the high financial
cost of treatments or drugs to manage side-effects such as
erectile dysfunction and uncertainty about how to cover
these costs. To overcome accessibility issues, these men
suggested use of online or telephone services for those in
rural or regional areas or who could not access care due
to ill health, lobbying the government to subsidise financial costs of treatment and increasing the availability of
home-based medical care or practical assistance services.
Shared experience/peer support
The opportunity to talk to other men in the same situation was discussed by most men as a source of support
that they had, or wished they had, an awareness of and
access to. Three aspects of shared experience/peer
support: benefits, delivery preferences and barriers were
described. Shared experience was highly valued by most
men because it allowed them to talk to someone who
had been through the same experience, obtain information or advice when weighing up treatment decisions or
managing side effects, make positive upward (eg, other
men doing well and inspiring hope for recovery) or
downward (eg, other men are doing worse so I am ok)
comparisons,29 gave men a safe and confidential forum to
express their concerns and helped men to feel less alone.
However, some men did not associate peer support or
10

being connected to support groups with the concept of
sharing mutual experiences. Rather discussed it in relation to the naturally occuring companionship with other
men from social or sporting clubs or Men’s Sheds.
Most men proposed different delivery methods for
peer support (eg, face-to-face, telephone or online) to
take into account individual differences and need for
privacy or anonymity. Both structured (eg, with a facilitator and an agenda) and unstructured (eg, a chat over
coffee) methods were acceptable. Some men preferred
shared experiences specifically for men with advanced
disease on the basis that men with localised disease have
different treatments and cancer-related physical effects.
Finally, despite acknowledging the benefits of shared
experience, many men also discussed barriers to peer
support use. These included feeling uncomfortable
to share in a group, the difficulty of sustaining support
groups, death of peers and the belief that support
groups were focused only on emotional or psychological
information.
Involvement of partner/family
In addition to shared experience, most men identified
partners and/or family and friends as sources of support
that contributed to their emotional and physical wellbeing. For most men, female partners were their main
source of emotional and practical support. Many men
discussed that partners were impacted by the diagnosis
and treatment of PCa and believed it was important to
involve and support partners in their care. Some men
commented that partners are often the catalyst for their
involvement in support groups or seeking out information/support from other sources. Broader family and
friends were also discussed by some men as sources of
support, often providing practical assistance.

Discussion
The present study extends previous research about the
experience of men with advanced PCa, adding an additional level of description that provides insight into how
health context influences men’s responses, the influence
of life course and ways in which masculinities is expressed
in this setting. As in previous research, difficulties with
accessible informational support about the disease and its
treatment were highly evident.19 20 30 That these problems
persist and are remarkably similar in Canada,19 Scotland20
and in our Australian data, is striking and suggests that
globally there may be a gap in health systems’ responses
to advanced PCa. PCa survivorship research has to date
been underfunded by comparison to breast cancer31; a
consensus about clinical care for advanced PCa is just
now emerging32 and the historical and persistent debate
about the early detection of PCa23 33 are likely contributors to this. The men’s reports in our study of PCa having
a less favourable public profile reflect this and show how
the broader public health and social context can have a
Chambers SK, et al. BMJ Open 2018;8:e019917. doi:10.1136/bmjopen-2017-019917
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referral. Some men believed this should be their GP;
others suggested their urologist or oncologist. Patient
advocates or navigators were also discussed by some men
as an option to help streamline and clarify the diagnostic
and treatment process. Some men discussed PCa nurses
as being central to their care. Nurses provided informational, emotional and practical support that clarified
men’s understanding of their situation, served as an intermediary between the patient or couple and other clinicians and were seen as more likely to refer them to other
beneficial services than other healthcare professionals.
These men discussed that the best time to be connected
with a PCa nurse was at diagnosis with continued access
throughout treatment.
Some men identified the need to integrate psychosocial support as part of routine care without relying on
men themselves to raise emotional issues with clinicians.
Alongside this, some men also discussed the need for
routine referral to support groups or information about
the existence of local groups and exercise programmes as
helpful for weight gain and muscle wastage and managing
feelings of loss of masculinity.
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Correction notice This article has been corrected since it first published. In the
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Abstract, "(metastatic or castration-resistant biochemical regression)" has been
corrected to "(metastatic or castration-resistant biochemical progression)".
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